Trigeminal Neuralgia and Treatments
Trigeminal Neuralgia and Treatments is a research topic within Pathology and Forensic Medicine. Science Explorer counts 15k research works in it since 1950. 10.0% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the pathology, pathogenesis, diagnosis, and management of trigeminal neuralgia, with an emphasis on microvascular decompression and radiosurgery as treatment modalities. It also explores the role of neurovascular compression, neuropathic pain, and the pathophysiology of trigeminal neuralgia.
- Trigeminal Neuralgia
- Microvascular Decompression
- Radiosurgery
- Neurovascular Compression
- Pathophysiology
- Diagnosis
- Treatment
- Neuropathic Pain
- Gamma Knife
- Neurological Surgery
- Research works
- 15k fractional, since 1950
- In the world top 10%
- 1.5k per year above
- Top-10% rate
- 10.0% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +16% the tick is no change
- Largest producer
United States
33% of the 10 largest, 2022-now
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Trigeminal Neuralgia and Treatments research?
By volume, the United States and China publish the most (758 and 424 works in 2022-now).
By volume, 2022-now
- 1
United States 758 works
- 2
China 424 works
- 3
India 220 works
- 4
Japan 187 works
- 5
Türkiye 146 works
- 6
Italy 144 works
- 7
South Korea 124 works
- 8
Germany 115 works
- 9
Brazil 105 works
- 10
United Kingdom 103 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Trigeminal Neuralgia and Treatments research?
By volume in 2022-now, Harvard University publishes the most Trigeminal Neuralgia and Treatments research, followed by Mayo Clinic and Capital Medical University.
By volume, 2022-now
- 1
Harvard University
United States 32 works
- 2
Mayo Clinic
United States 29 works
- 3
Capital Medical University
China 27 works
- 4
Shanghai Jiao Tong University
China 24 works
- 5
Neurological Surgery
United States 23 works
- 6
All India Institute of Medical Sciences
India 19 works
- 7
Johns Hopkins University
United States 18 works
- 8
Stanford University
United States 18 works
- 9
Case Western Reserve University
United States 17 works
- 10
University of Copenhagen
Denmark 15 works
Who are the leading researchers in Trigeminal Neuralgia and Treatments?
The most-cited researchers publishing on Trigeminal Neuralgia and Treatments include Karl John Friston and Isabela M. Benseñor.
- 1
Karl John Friston
United Kingdom 310k citations
- 2
Isabela M. Benseñor
Brazil 245k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Trigeminal Neuralgia and Treatments research done?
The largest centres of Trigeminal Neuralgia and Treatments research in 2022-now are Beijing (China), Seoul (South Korea), Tokyo (Japan) and Istanbul (Türkiye). Among places with at least 20 works in it, it is an unusually large share of all research in Rockville Centre and Cleveland.
Largest cities, 2022-now
Where it is the local speciality
- Rockville CentreUS · 22.7 works51×
- ClevelandUS · 25.3 works5.6×
Location quotient: how much more of its research is in Trigeminal Neuralgia and Treatments than the world average.
Where is the best place to study Trigeminal Neuralgia and Treatments?
Among universities, judged by research, University of Copenhagen, Harvard University and Johns Hopkins University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Trigeminal Neuralgia and Treatments, country by countryIs Trigeminal Neuralgia and Treatments research growing?
Output in 2022-2025 was 16% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Trigeminal Neuralgia and Treatments.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Trigeminal Neuralgia and Treatments as a percentage of every work published that year, 0.013% in 2024.
Fractional works of Trigeminal Neuralgia and Treatments over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Trigeminal Neuralgia and Treatments. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.